Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk

Cardiovascular Risk and Diseases

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

BMJ.

Hippisley-Cox J, Coupland C, Brindle P

doi: 10.1136/bmj.j2099.

RECOMMENDED

Cardiovascular Risk and Diseases

Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

Eur Heart J Acute Cardiovasc Care.

Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E, Cobain M, Piepoli MF, Visseren FL, Dendale P

doi: 10.1177/2048872619858285.

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator

Circulation.

Khera A, Budoff MJ, O'Donnell CJ, Ayers CA, Locke J, de Lemos JA, Massaro JM, McClelland RL, Taylor A, Levine BD

doi: 10.1161/CIRCULATIONAHA.

COMMENTED

Lipid-Lowering Drugs

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting

Eur Heart J.

Verbeek R, Hoogeveen RM, Langsted A, Stiekema LCA, Verweij SL, Hovingh GK, Wareham NJ, Khaw KT, Boekholdt SM, Nordestgaard BG, Stroes ESG

doi: 10.1093/eurheartj/ehy334.

Cardiovascular Risk and Diseases

Family history and polygenic risk of cardiovascular disease: Independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy

Atherosclerosis.

Timmerman N, de Kleijn DPV, de Borst GJ, den Ruijter HM, Asselbergs FW, Pasterkamp G, Haitjema S, van der Laan SW

doi: 10.1016/j.atherosclerosis.

Cardiovascular Risk and DiseasesLipid-Lowering Drugs

Lipoprotein(a) and Cardiovascular Risk Prediction Among Women

J Am Coll Cardiol.

Cook NR, Mora S, Ridker PM

doi: 10.1016/j.jacc.2018.04.060.

Heart, Artery and Coronary DiseasesMyocardial InfarctionThrombosis and Stroke

Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection

Circulation.

Triant VA, Perez J, Regan S, Massaro JM, Meigs JB, Grinspoon SK, D'Agostino RB Sr.

doi: 10.1161/CIRCULATIONAHA.

Cardiovascular Risk and Diseases

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Lancet Glob Health.

WHO CVD Risk Chart Working Group.

doi: 10.1016/S2214-109X(19)30318-3.

Cardiovascular Risk and Diseases

Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

JAMA.

Lin JS, Evans CV, Johnson E, Redmond N, Coppola EL, Smith N

doi: 10.1001/jama.2018.4242.

Related content

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting

Family history and polygenic risk of cardiovascular disease: Independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy

Lipoprotein(a) and Cardiovascular Risk Prediction Among Women

Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions

Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force